Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cold Stored Platelets for Aspirin Reversal (RASP)
NCT05111028Phase 2Unknown
- Sponsor
- Bloodworks Northwest
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cold-stored platelet concentrate (2 arms), sponsored by Bloodworks Northwest. Primary endpoint: Glycoprotein IIb/IIIa activation at 1 hour post transfusion. Status: unknown.
02
Drugs
cold-stored platelet concentrate
Beyond the preview
Go deeper on NCT05111028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05111028.